26772-34-9Relevant articles and documents
Synthesis method of weather-resistant epoxy resin curing agent
-
Paragraph 0041-0059, (2021/10/13)
The invention discloses a synthesis method of a weather-resistant epoxy resin curing agent. The method comprises the following steps of: enabling cyclohexanedicarboxylic acid and azidoformic acid 2, 2, 2-trichloroethyl ester to react under the catalysis of DMAP and copper acetate to generate an intermediate b, and enabling the intermediate b to react with potassium carbonate to generate 1, 3-bis (aminomethyl) cyclohexane. According to a traditional synthesis method of 1, 3-bis (aminomethyl) cyclohexane, m-xylylenediamine (MXDA) is subjected to benzene ring hydrogenation reduction to prepare the 1, 3-bis (aminomethyl) cyclohexane. The invention provides the novel synthesis method of 1, 3-bis (aminomethyl) cyclohexane (1, 3-BAC), and the method is simple in process.
Discovery and structure-activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators
Zhou, Hao,Topiol, Sidney W.,Grenon, Michel,Jimenez, Hermogenes N.,Uberti, Michelle A.,Smith, Daniel G.,Brodbeck, Robbin M.,Chandrasena, Gamini,Pedersen, Henrik,Madsen, Jens Christian,Doller, Darío,Li, Guiying
, p. 1398 - 1406 (2013/03/14)
A novel series of trans-1,3-cyclohexyl diamides was discovered and characterized as mGluR5 negative allosteric modulators (NAMs) lacking an alkyne moiety. Conformational constraint of one of the amide bonds in the diamide template led to a spirooxazoline template. A representative compound (24d) showed good in vitro potency, high CNS penetration and, upon subcutaneous dosing, demonstrated efficacy in the mouse marble burying test, generally used as indicative of potential anxiolytic activity.
Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists
Giordanetto, Fabrizio,Karlsson, Olle,Lindberg, Jan,Larsson, Lars-Olof,Linusson, Anna,Evertsson, Emma,Morgan, David G.A.,Inghardt, Tord
, p. 4232 - 4241 (2008/12/21)
We herein report the optimization of cyclopentane- and cyclohexane-1,3-diamine derivatives as novel and potent MCH-R1 antagonists. Structural modifications of the 2-amino-quinoline and thiophene moieties found in the initial lead compound served to improve its metabolic stability profile and MCH-R1 affinity, and revealed unprecedented SAR when compared to other 2-amino-quinoline-containing MCH-R1 antagonists.